FDA Approved: TRAVATAN Z — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for Travatan Z (travoprost) from Novartis Pharmaceuticals Corporation. This action updates the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• TRAVATAN Z (TRAVOPROST)

Snippet

SUPPL AP for TRAVATAN Z (TRAVOPROST)